Introduction
============

Many clinical disorders are characterized or accompanied by GI alterations, including symptoms such as discomfort or pain, bloating and altered motility which can negatively impact a patient's quality of life. For example, irritable bowel syndrome, a chronic, relapsing GI problem ([@B85]) with a high overall prevalence ranging from 10 to 20% of the population ([@B27]), is also highly comorbid with other pathologies including depression and anxiety, cardiovascular disease and fibromyalgia ([@B12]; [@B64]; [@B25]; [@B19]). In the past decade, this intricate connection between the GI and other systems has received deep attention allowing for the coining of terms such as gut-brain axis ([@B23]), gut-liver axis ([@B20]), or gut-kidney axis ([@B43]). Likewise, the number of papers addressing the contribution of intestinal microbiota (which may be considered "an organ within an organ") aspects to the above axes has increased exponentially in the last few years.

The adequate relationship between GI physiology and overall homeostasis involves a variety of delicate functions; among these, the participation of gut motility, intestinal epithelial secretion and visceral perception mechanisms in association to systemic alterations have been somewhat explored ([@B16]; [@B44]; [@B110]; [@B103]; [@B15]; [@B104]). However, the contribution of other complex responses such as those regulated by the ENS or the intestinal epithelial barrier to the development of GI and extraintestinal disorders are still largely unknown. Regarding the association between gut barrier modifications and disease, abundant but mostly observational data is available (see Table [1](#T1){ref-type="table"}). These evidences strongly suggest the involvement of an altered barrier in either the origin or the manifestations of these diseases, although the exact mechanisms are yet to be investigated. A few recent temporal, genetic and twin studies have looked into the potential role of a dysfunctional gut barrier in the onset of disease ([@B92]; [@B90]; [@B40]). Still, the pathogenesis of inflammatory gut diseases is unclear, and although the previous reports somewhat point to barrier-associated factors (including genetic predisposition and unfavorable luminal environment conditions) further exploration of this hypothesis is still needed. Appropriate animal models may allow addressing such mechanistic questions, while also allowing to test potential treatments for pathologies that are characterized by enhanced intestinal permeability.

###### 

Disorders associated with increased gut permeability.

  -------------------------------------------------------------------------------------- -----------------
  **Gastrointestinal disorders associated with gut barrier alterations**                 
  Inflammatory bowel disorders                                                           [@B83]; [@B97]
  Celiac disease                                                                         [@B33]
  Food allergies                                                                         [@B67]
  Infectious diarrhea                                                                    [@B79]; [@B34]
  Irritable bowel syndrome                                                               [@B7]
  **Extraintestinal disorders and conditions associated with gut barrier alterations**   
  Critical illness and multiple organ dysfunction syndrome                               [@B107]
  Burn injury                                                                            [@B111]; [@B17]
  Heart failure                                                                          [@B75]
  Renal failure                                                                          [@B55]; [@B94]
  Liver disease                                                                          [@B77]
  Rheumatologic disorders                                                                [@B10]
  Dermatologic disorders                                                                 [@B35]; [@B56]
  Diabetes                                                                               [@B3]; [@B76]
  Depression                                                                             [@B54]
  Schizophrenia                                                                          [@B78]
                                                                                         
  -------------------------------------------------------------------------------------- -----------------

Factors Influencing the Gut Barrier Function
============================================

The GI tract has an estimated surface area of 32 m^2^ ([@B32]). Being constantly exposed to microbes and potentially damaging or immunogenic substances (i.e., bacterial, dietary and xenobiotic components and their metabolites) it requires a selective and efficient barrier function. This is composed of several main layers: more externally, the gut microbiota; a mucus gel coat acting as a physical diffusion layer; and the epithelium, responsible for secretion, absorption, endocrine and immune functions, to name a few.

Regarding the gut microbiota, it has been well shown that the absence of luminal bacteria at key developmental stages drastically affects the maturation of the gut barrier ([@B98]; [@B84]). Animals reared in germ-free conditions display striking alterations in the morphology as well as in several immune, biochemical and biophysical parameters of the intestinal barrier. Also these germ free animals have alterations in the ENS, such as reduced neuron excitability ([@B60]). Likewise, reduced intestinal virome diversity and altered intestinal barrier function are associated not only with infectious and autoimmune diseases but also metabolic disorders and cardiovascular disease ([@B8]).

Most bacteria and viruses do not contact the gut epithelium directly due to the presence of mucus. The intestinal mucus gel coat is produced by a subset of epithelial cells known as goblet cells and contains mucins, highly glycosylated proteins that form a viscoelastic network. Important defense functions are exerted by the intestinal mucus: it acts as a physical diffusion barrier to pathogens and contains antimicrobial peptides and immunoglobulins, produced by mucosal Paneth cells and plasma B cells, respectively ([@B39]).

The intestinal epithelium also restricts the passage of microbes and substances from the luminal space to the systemic compartment. Its main cell type are enterocytes which absorb nutrients, water and electrolytes and can also secrete water and electrolytes. Enterocytes connect to each other through protein structures, namely desmosomes and adherens junctions, integrins and tight junctions ([@B13]). These protein complexes are key to modulate the paracellular transport of substances across the epithelium, which represents the predominant means of gut epithelial permeability ([@B88]). Tight junctions (TJ) allow the movement of water, small solutes and electrolytes between epithelial cells, but restrict the translocation of larger molecules. TJ function is dynamic and can be regulated by factors associated to cellular stress, gut microbes and dietary compounds ([@B22]). The transepithelial transport of compounds with high molecular weight is achieved via the transcellular pathway, which includes the processes of carrier-dependent transport and endocytosis, important for nutrient absorption. Increased permeability via the transcellular but especially the paracellular pathway can allow for excessive translocation of microbial and diet-derived molecules, potentially contributing to inflammatory conditions ([@B22]).

Another gut epithelial cell type are enteroendocrine cells, capable of releasing endocrine mediators. They have been called "sentinels of the intestinal environment" ([@B101]) and are able to regulate intestinal inflammation by enhancing secretion of the anti-inflammatory mediator GLP-1 ([@B48]). According to the authors, gut injury-associated increase in permeability is believed to allow LPS access to stimulate a subtype of enteroendocrine cells, resulting in GLP-1 secretion. This peptide would favor mucosal integrity by attenuating local and systemic inflammation.

The gut mucosa is not only composed of epithelial cells. Immersed in the intestinal epithelium are immune cells which upon contact with luminal material are able to coordinate adequate responses either to prevent microbial invasion ([@B52]) or to dampen down exaggerated immune reactions ([@B91]). Additionally, these mucosal immune cells exert modulatory functions over the intestinal barrier; for example, T helper cell-derived cytokines can help modify the flux of molecules across tight junctions or cation pores ([@B91]). If microbes surpass the intestinal epithelium, they are eliminated by macrophages from the lamina propria ([@B42]) in a process characterized by the lack of a strong proinflammatory tone ([@B82]). In addition, upon damage macrophages migrate to the injured area and promote epithelial tissue repair ([@B71]).

In addition to immune cells, the gut wall contains neurons which are another important aspect in the modulation of intestinal barrier permeability. Mediators released by the ENS, which is organized in submucosal and myenteric plexi, can modulate not only paracellular permeability, water/electrolyte transport and nutrient absorption but also wound healing, in particular the process of epithelial proliferation/differentiation ([@B65]).

Intestinal barrier function is critical for gut homeostasis. A breach in this barrier can be originated by improper function of one or more of its cell types, including inadequate interaction between epithelial cells associated not only to alterations of the tight junctions but also weakened intercellular adherent connections ([@B96]). As such, abnormal intestinal permeability is an important component in dysfunctional gut barrier-associated disorders such as IBD and celiac disease ([@B26]). Altered permeability has been associated to several human diseases (see Table [1](#T1){ref-type="table"}) in the GI and other systems. The traditional view that defines increased permeability as a mere consequence of disease processes is now outdated; alterations in the translocation of luminal substances are currently being considered as part of disease etiopathogenesis ([@B40]). Therefore, there is increasing need for animal models of gut permeability not only to test palliative therapies but to further investigate disease etiology and subsequently propose novel pharmacological targets. Fortunately, many functional, cellular and biochemical features of the intestinal barrier are conserved among species; for example, a high degree of similarity is observed between tight junction proteins across vertebrates ([@B74]; [@B6]).

Methods for Testing Gut Permeability and Other Markers of Barrier Disruption
============================================================================

When testing for intestinal permeability, a variety of parameters can be evaluated. Moreover, the fact that permeability varies along the GI tract must be taken into account, being the small intestine more permeable than the large intestine ([@B58]). Excellent reviews are available ([@B99]; [@B21]; [@B22]) which summarize the most commonly used permeability tests for both basic and clinical research, in order to evaluate the status of epithelial barrier integrity, the pathophysiology of leaky gut alterations or to prove the effectiveness of treatment.

Briefly, methods for testing gut permeability *in vivo* involve the administration of a tracer molecule by oral gavage or intestinal instillation. Tracers commonly used are non-digestible sugars such as lactulose or mannitol, PEG, fluorescently labeled dextrans and ^51^Cr-EDTA (see [@B22] for applications, advantages and limitations of these and other tracers), which can be later quantified in urine or blood. The size of a tracer can indicate the probable route of permeability: for example, 4 kDa dextrans are able to pass through the paracellular route. This is also the case for mannitol and ^51^Cr-EDTA. On the other hand, larger molecules like 40 kDa HRP are commonly associated to the transcellular pathway ([@B22]). The output in most of these techniques is a single value of permeability, which does not allow to discern which region of the GI is being affected, and therefore must be used in combination with other methods ([@B22]). Also, factors affecting the distribution and excretion of orally administered probes, such as gastric emptying, intestinal transit, bacterial degradation, intestinal blood flow, as well as the timing of blood or urinary collection should be taken into consideration ([@B2]).

Short term culture of tissue explants for *ex vivo* permeability tests has the advantage of allowing for the evaluation of very specific regions of the GI tract and also maximizes data output in expensive or lengthy treatments. However, tissue viability is a major concern and therefore incubation times no longer than 3 h are recommended ([@B11]). The use of everted gut sacs to measure the transit of fluorescent probes has the advantage of not demanding specialized equipment, but larger amounts of tissue are required (3--4 cm^2^) ([@B63]; [@B18]). In the Ussing chamber, ion transport across the intestinal wall can be measured in very small segments of tissue (1 cm^2^) but a more expensive setup is necessary. Here, the degree of TEER is considered an inverse correlate to the extent of paracellular permeability ([@B11]). Although there has been some debate around whether TEER represents trans- or paracellular permeability, its close association to the tight junction protein dynamics ([@B86]) makes us agree to the latter. Since the apical and basolateral sides are kept in isolated chambers, the passage of tracers can also be evaluated. FITC-dextrans, ^51^Cr-EDTA and HRP have been used to evaluate paracellular and transcellular permeability, respectively ([@B22]). The Ussing chamber can also be used to evaluate permeability across monolayers of cultured epithelial cells ([@B5]), such as the Caco-2 cell line, which polarize under appropriate growth conditions. In cell monolayers, TEER measurements can also be performed in an ohm-volt meter ([@B109]), a simpler device when compared to the Ussing chamber + voltage clamp apparatus.

In order to obtain comprehensive information regarding epithelial leakiness it is recommended that *in vivo* and *ex vivo*/*in vitro* tests of permeability are used in combination with the detection of permeability-associated biomarkers ([@B22]). For example, the presence of microbial products or the corresponding antibodies in the blood is an indirect evidence of barrier breach ([@B89]; [@B93]). These strategies allow for testing in a less invasive, non-terminal fashion but again, do not allow discerning which region of the GI is being affected. On the other hand, evaluating (a) mucosal morphology (including villus and/or crypt length, inflammatory cell infiltration, etc.) ([@B50]), (b) the presence of tracer particles in pinocytic vesicles within gut absorptive cells ([@B100]), together with (c) tight junction/inflammatory protein and/or mRNA expression are more invasive, usually terminal strategies that provide information regarding the site and potential mechanism of damage ([@B87]; [@B36]).

Studying Gut Barrier Alterations in Animal Models
=================================================

The gut barrier is structurally and biochemically conserved across species, as mentioned before. Both in humans and rodents the intestinal barrier function is highly sensitive to stress, dietary and microbiota changes. Therefore, we must consider that most animal models involving a modification in the environment could display changes in gut permeability to some extent. However, to the purpose of investigating mechanisms of disease and suitable treatments, a model should follow at least some of the following criteria ([@B95]): (1) face validity, meaning that the modifications observed in animal biochemistry, physiology and/or behavior should resemble those observed in human patients; (2) construct validity, which implies that the etiology of human disease was considered when establishing the model (i.e., alcohol is given to rats to model alcoholic liver disease) and (3) predictive validity, which means that the animal model should respond to interventions (such as pharmacological treatments) in the same way a human patient would. [@B95] propose that the relevance of a model relies on its external validity, which according to the authors depends largely on using combined evaluations of predictive, diagnostic and construct validity. In our opinion, depending on the particular use of a model (mechanistic studies, screening of therapeutic compounds, etc.) we could choose two or even one criteria of validity; however reaching all three would provide a more robust model.

With regards to gut barrier alterations, most animal models share a common feature: they display enhanced epithelial permeability. Rodents are typically used, although other animals, such as porcine ([@B45]), equine ([@B57]) and avian models ([@B38]; [@B1]), have also been described, to name a few. The last three are particularly useful to investigate veterinary conditions including early weaning, anti-inflammatory drug, feed contamination or restriction, respectively. However there are also reports indicating the suitability of these species to model human diseases that are associated with disrupted gut permeability, as we will mention later.

Intestinal barrier disruption can be achieved by directly intervening on the intestinal environment, or indirectly by targeting another system that communicates to the gut. The latter is the basis for stress- or lesion-induced models that display altered gut permeability. In some cases, however, it is difficult to discern whether a combined effect has been achieved: for example, DSS (an agent that can be added to the animal's drinking water) is commonly used to chemically damage the mouse or rat intestinal epithelium inducing epithelial leakiness and an inflammatory colitis that resembles IBD in humans ([@B72]), however, it could also indirectly affect the brain-gut axis by causing discomfort and stress to the rodent ([@B37]), which are known to also enhance intestinal permeability ([@B61]). Taking this in consideration, the following classification of models refers only to the initial stimuli or intervention applied to the experimental animal (see Table [2](#T2){ref-type="table"} for a further description).

###### 

Examples of experimental approaches to model increased gut permeability.

  Species and type of model                                                     Observations                                                                                                                                                                                                    Mechanism proposed by author                                                                                                                                                                       Reference
  ----------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------
  **Intestinal models**                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Mice, oral cadmium exposure (100 mg/L CdCl~2~ for 8 week)                     Increased gut permeability and proinflammatory cytokine expression. Decreased tight junction protein expression. Reversed by oral probiotic administration                                                      Genotoxicity, death of epithelial cells, damage to tight junctions, gut dysbiosis                                                                                                                  [@B106]
  Mice, sepsis induced by CLP                                                   Enhanced permeability to FD4 and increased expression of Claudin 2 and JAM-A. Decreased expression of Claudin 5 and Occludin                                                                                    NA                                                                                                                                                                                                 [@B105]
  Rats, allergy induced by oral administration of ovoalbumin                    Erosive damage in small intestine. Increased lactulose/mannitol ratio. Altered morphology of tight junctions and decreased expression of tight junction proteins                                                Inflammation in intestinal tract during allergy induction by OVA                                                                                                                                   [@B9]
  Mice, colitis induced by oral administration of DSS (3% for up to 7 days)     Loss of ZO-1 and increased permeability to Evan's Blue dye                                                                                                                                                      Toxic effect on the colonic epithelial cells and crypts leading to changes in the TJ complex and in mucosal permeability prior to the inflammatory infiltrate                                      [@B69]
  Rats, colitis induced by anal infusion of TNBS (20 mg)                        Decreased expression of ZO-1 and Occludin in colon. Increased levels of endotoxin in serum and colon                                                                                                            Hapten-induced chronic inflammation                                                                                                                                                                [@B102]
  Swine, rectal mucosal lesions induced by TNBS enema (15 mg/ml, 15 min)        Acute increase in paracellular and transcellular permeability. Disrupted localization of ZO-1 in rectal mucosa                                                                                                  Inflammation associated to overexpression of IL-1β, IL-4, IL-10, IFNα and IFNγ                                                                                                                     [@B4]
  Mice, infection with *Citrobacter rodentium*                                  Tight junction disruption associated to attachment of the pathogenic bacteria to the cells                                                                                                                      Alteration of claudin-3 localization dependent on the intimate attachment of the pathogen to the colonic enterocytes, and independent on inflammation                                              [@B29]
  Chickens, infection with several *Eimeria* species                            Increased expression of ovotransferrin in the colon. Increased fecal ovotransferrin levels                                                                                                                      Release of pro-inflammatory cytokines due to coccidial-induced inflammatory response in the gut                                                                                                    [@B24]
  Mice, CLP                                                                     Increased plasma bacterial load and TNF expression                                                                                                                                                              Excessive bacterial load leading to septic inflammatory response                                                                                                                                   [@B66]
  Chickens, 24 h feed restriction                                               Increased permeability to FD4                                                                                                                                                                                   Increased levels of plasma corticosterone leading to disruption of gut barrier integrity and local inflammation                                                                                    [@B1]
  Rats, low protein diet (4% for 20 days)                                       Decreased mucosal tight junction protein expression and reduced TEER in the colon.                                                                                                                              Changes in epithelial cell differentiation                                                                                                                                                         [@B18]
  Rats, high fat diet (45% for up to 6 weeks)                                   Increased flux of HRP flux in correlation with time on the diet                                                                                                                                                 Early and region-specific changes in the gut microbiota which correlate with alterations in gut epithelial function                                                                                [@B30]
  **Extraintestinal models**                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Mice, pneumonia induced by *Pseudomonas aeruginosa.*                          Enhanced permeability to FD4 and increased expression of Claudin 2 and JAM-A. Decreased expression of Claudin 5, ZO-1 and Occludin                                                                              NA                                                                                                                                                                                                 [@B105]
  Mice, low-dose ionizing radiation (4 Gy)                                      Redistribution of tight junctions, adherens junctions and actin cytoskeleton in colon mucosa. Increased permeability to FITC-inulin                                                                             Ablation of crypt cell proliferation, mitotic catastrophe, and apoptosis leading to gastrointestinal mucositis                                                                                     [@B81]
  Mice, burn injury (85°C, 20% body area)                                       Increased permeability to FD4. Reduced expression of Claudin 4 and 8                                                                                                                                            Rapid and systemic inflammatory response, including mesenteric vasoconstriction leading to gut hypoxia and cell death                                                                              [@B17]
  Rats, brain injury (20 g from a height of 30 cm)                              Increased lactulose/mannitol ratio. This is reversed by oral probiotic administration                                                                                                                           Intestinal ischemia and hypoxia. Enhanced cell catabolism resulting in depletion of intestinal mucosa main fuel.                                                                                   [@B108]
  **Extraintestinal models**                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Rats, hyperthermia (up to 42.5°C, 90 min)                                     Increased gut permeability to FD4 and marked intestinal epithelial damage                                                                                                                                       Reduced blood flow to the GI tract resulting in hypoxia, free radical production, ATP depletion, acidosis, and disruption of intestinal epithelial membranes that results in enterocyte necrosis   [@B47]
  Mice, acute cold exposure (4°C, 30 min)                                       Increased permeability to L-arabinose. Increased Claudin 2 mRNA expression                                                                                                                                      Adjustments to the tight junction in order to increase paracellular permeability to nutrient-sized molecules, to meet enhanced digestive/absorptive demand                                         [@B70]
  Rats, acute restraint stress (2 h)                                            Transient increase in ileal epithelial permeability to alanthanum tracer. Irregular distribution of occludin and ZO-1                                                                                           Stress-induced contraction of the actin cytoskeleton increasing the distance between adjacent enterocytes                                                                                          [@B59]
  Rats, water avoidance stress (1 h daily for 7 days)                           Decreased TEER, increased flux of HRP and altered expression of Claudin 2, JAM-A and ZO-1 in colon                                                                                                              Sub-inflammatory increase in proinflammatory cytokines which mediates the alteration of TJ protein expression                                                                                      [@B31]
  Rats, maternal deprivation (one single 4 h event)                             Increased gut permeability to FD4 4 and 8 h after deprivation. Increased bacteria translocation to liver and spleen 10 days after deprivation. This is reversed by RU486 (glucocorticoid receptor antagonist)   Increased corticosterone plasma levels is associated to MLCK-dependent cytoskeleton contraction in epithelial cells                                                                                [@B62]
  Mice, intensive treadmill exercise (80% of their VO~2~max until exhaustion)   Increased permeability to FD4, electrogenic ion transport and tissue conductance of the small intestine. Also enhanced apoptosis of small intestinal epithelial cells                                           Gastrointestinal ischemia-associated alterations in epithelial integrity followed by fast repair processes in the duodenum                                                                         [@B28]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

CLP: cecal ligation and puncture. DSS: dextran sulfate sodium. FD4: fluorescein isothiocyanate-dextran 4,000 Da. HRP: horseradish peroxidase. IFN: interferon. IL: interleukin. JAM: junctional adhesion molecule. MLCK: myosin light chain kinase. NA: not available. TEER: transepithelial electrical resistance. TNBS: trinitrobenzene sulfonic acid. ZO: zonula occludens.

Models in Which Barrier Dysfunction Is Established on the Gut
-------------------------------------------------------------

Here, the initial intervention is either applied or originated at the GI lumen. Dietary and microbiota changes can protect the intestinal barrier function, which is the case for glutamine ([@B49]), bacteria-derived lactic acid ([@B73]) and butyrate ([@B41]). Other interventions disrupt the gut barrier, as in the case of DSS ([@B69]), TNBS ([@B4]; [@B102]) or heavy metal supplementation ([@B106]), low protein ([@B18]) or high fat diet ([@B30]), infection ([@B29]; [@B24]) or CLP ([@B66]). These models can be considered to have good construct validity for organic diseases (i.e., those where morphological and/or biochemical features are altered) where barrier function is compromised. For example, DSS or TNBS supplementation in rodents and IL-10 knockout mice are well known models of colitis ([@B80]; [@B51]; [@B102]), which is achieved through different mechanisms: DSS induces epithelial injury with exposure of the lamina propria and submucosa to luminal antigens, resulting in inflammation which ultimately alters the gut barrier; TNBS acts as a hapten and also induces inflammation but through Th1-mediated immune responses, which has been shown both in murine ([@B53]) and swine models ([@B4]). IL-10 knockout mice spontaneously develop bowel inflammation, which is associated to colon dysbiosis ([@B80]). On the other hand, CLP is used to simulate sepsis ([@B105]).

Human gut biochemical features that are commonly associated with perpetuation of intestinal barrier loss (i.e., local proinflammatory cytokines, proteases, neurotransmitters, pathogen-derived products) have been functionally evaluated by using well described gut-derived cell lines such as Caco-2. Here, a cell monolayer is exposed to cleared supernatants obtained from intestinal biopsies, explants or feces. Later, intestinal barrier markers and permeability parameters can be assessed in the cells ([@B68]). We believe that similar experimental designs could be used to demonstrate that soluble mediators generated at the animal model gut, which are considered to be involved in epithelial barrier disease mechanism, are functionally relevant.

Models in Which Gut Barrier Dysfunction Is Established Outside the Gut
----------------------------------------------------------------------

Lesion induction by skin burn, head trauma, radiation as well as shock induced by hyper- or hypothermia are all considered indirect interventions that increase intestinal permeability. Similar gut alterations are observed when acute or chronic stress is induced by brief water deprivation, motion restraint, overcrowding or forced swim, among others. In all the above cases, the initial disruption is believed to affect systems that are different from the GI, and therefore gut permeability is indirectly enhanced. From the construct validity point of view, these strategies may be more adequate to model barrier function alterations that are subsequent to previous stress or injury, or functional diseases where no morphological and/or biochemical markers are known yet.

Not every increase in gut permeability is associated to disease; for example, exhausting exercise in athletes is followed by marked increases in gut permeability ([@B46]), without known pathological consequences that aren't attributable to dehydration or heat stress ([@B14]). Therefore, an effort should be made to prove causality, especially when the injuring stimuli is not directly related to intestinal physiology in an animal model, but gut permeability is proposed as part of the disease mechanism.

Concluding Remarks
==================

Empiric evidence obtained from animal models, including not only correlation studies but also mechanistic designs allow us to propose (or refuse) particular aspects of barrier function as potential pathways to disease. For example, altered intestinal permeability is described in many chronic diseases; whether it constitutes a risk factor or a target for developing therapies must be established by means of a proper experimental setup.

The complexity of gut barrier function has a lot to do with its connections to other systems. Most of these are not fully understood and therefore, this research is still at its early years. Concomitant alterations in the microbial community, ENS and local immune system should be taken into consideration when interpreting data from animal models, in order to propose significant mechanisms or effective therapeutic strategies for multifactorial diseases. Some future research aims include:

1.  Implementing experimental approaches that allow for continuous monitoring of these events, taking into consideration that gut barrier function and especially epithelial permeability are dynamic phenomena.

2.  Investigating the variability of sign/symptom severity that arises from applying single or multiple stimuli, in order to better represent acute or chronic features of disease.

3.  Including more detailed characterization by reporting several outputs that reflect different elements and consequences of a gut barrier breach, i.e., permeability tests + intestinal epithelial changes + microbial products in the blood + inflammatory changes in the gut or other organs.

4.  Minimizing confounding factors such as inconsistencies at sampling timing, unwanted stress, and all environmental variables that can disturb barrier function.

Glossary
========

Dysbiosis
---------

Imbalance in the microbial communities that reside a living organism, either by changes in quantity or quality.

ENS
---

Intrinsic nervous system of the GI tract. It regulates vital GI functions, including motility, secretion, local immunity, and tissue repair.

Microbiota/Microbiome
---------------------

Microbiota is the collection of bacteria, viruses, fungi, and other microorganisms that reside a living organism. Microbiome is the name given to the genes contained in these microbes.

Tight Junctions
---------------

Multiprotein complexes that join two adjacent cells together to form a barrier. The connection involves transmembrane and scaffold proteins, as well as cytoskeleton components.

Virome
------

Collection of viruses and associated nucleic acids that reside a living organism.
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CLP

:   cecal ligation and puncture

DSS

:   dextran sulfate sodium

ENS

:   enteric nervous system

FD4

:   fluorescein isothiocyanate-dextran 4,000 Da

FITC

:   fluorescein isothiocyanate

GI

:   gastrointestinal

HRP

:   horseradish peroxidase

IBD

:   inflammatory bowel disease

IL

:   interleukin

JAM

:   junctional adhesion molecule
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:   polyethylene glycol

TEER

:   transepithelial electrical resistance

TNBS

:   trinitrobenzene sulfonic acid

ZO

:   zonula occludens
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